
Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV
Description
About Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV
The Mpox virus (MPXV) Putative nuclease OPG089 Peptide (IEDB: 26990) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Putative nuclease OPG089 Peptide, H-ILDDNLYKV-OH (Uniprot: A0A7H0DN61 aa: 18-26) from JPT is produced under strict quality control and quality management.
Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV - Specifications
- Peptide sequence: H-ILDDNLYKV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in plastic vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV
References:
Read References with JPT’s Antigen Peptides
Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV has been described in:
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara., J Immunol, 2005 (PMID: 16339586)
HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation., Proc Natl Acad Sci U S A, 2005 (PMID: 16172378)
Documentation
Documentation for Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV
Properties
Properties of Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial, Freeze-dried in plastic vial |
Organism: | Mpox virus (MPXV) |
Protein Name: | Putative nuclease OPG089 |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Mpox virus Putative nuclease OPG089 18-26, ILDDNLYKV
Information | Values |
---|---|
Sequence: | H-ILDDNLYKV-OH |
Specifications: | 9mer peptide as TFA salt |